Research and Development

ASC 730 identifies which activities and cost elements constitute research and development and requires that R&D costs within its scope be charged to expense when incurred (730-10-25-1), because the future benefits are too uncertain to justify capitalization (730-10-05-2 through 05-3). Subtopic 730-10 supplies the definitions, cost elements (including the "alternative future use" test for materials, equipment, facilities, and purchased intangibles), scope exclusions (contract R&D for others, extractive industries, routine alterations, market research, and R&D assets acquired in a business combination, NFP acquisition, or JV formation), and the requirement to disclose total R&D expense for each income statement period (730-10-50-1). The remaining subtopics address special settings: 730-20 looks to the substance of externally funded R&D arrangements (contract to perform R&D for others versus an in-substance liability to repay the funding parties) and imposes disclosure of significant agreement terms; 730-912 lets federal government contractors in best-efforts cost-sharing arrangements meeting all six conditions of 730-912-15-2 expense costs as R&D and record customer funding as an offset to aggregate R&D expense rather than revenue; and 730-985 is purely a cross-reference to the software guidance in 985-20. The unifying idea is immediate expense recognition, with substance-over-form governing how funding and arrangements are characterized.

Subtopics

1. 10Overall24 ¶

   ASC 730-10 governs the identification and accounting for research and development (R&D) costs. The core rule is that R&D costs within scope are charged to expense when incurred (730-10-25-1), because future benefits are too uncertain and unmeasurable to support asset recognition (730-10-05-2 through 05-3). The subtopic also defines which activities count as R&D, which cost elements are R&D costs, and requires disclosure of total R&D expense for each income statement period.

   0005101525505560
2. 20Research and Development Arrangements42 ¶

   ASC 730-20 governs how an entity accounts for arrangements in which other parties (often a limited partnership of investors) fund the entity's research and development. The central question is the substance of the entity's obligation: whether the entity has merely contracted to perform R&D services for others, or has in substance incurred a liability to repay the funding parties. Substance governs over form, so payments labeled royalties or option/purchase prices may in fact be settlement of a borrowing, the purchase price of an asset, or true royalties.

   000510152535506065S00S55S99
3. 912Contractors—Federal Government10 ¶

   This subtopic tells government contractors how to account for best-efforts-basis, research-and-development-cost-sharing arrangements with the federal government. When all six scope conditions in 730-912-15-2 are met (qualifying R&D, contractor retains rights to data/results, best-efforts-only obligation, mutual expectation that costs will exceed funding, no contract combination under 606-10-25-9, and the federal government as sole or principal ultimate customer), the arrangement is not a revenue contract under Topic 606. Instead, costs are expensed as R&D as incurred under Topic 730, and customer funding is recorded as an offset to aggregate R&D expense rather than as contract revenue (730-912-25-1).

   0005152555
4. 985Software3 ¶

   ASC 730-985 is a "link" subtopic: it contains no substantive rules of its own but points readers from the research and development Topic to the software guidance. It directs users to 985-20-25-1 for costs incurred to establish the technological feasibility of software to be sold, leased, or otherwise marketed, and to 985-20-25-8 through 25-10 for the cost of purchased software to be marketed.

   0525